Maternal Immunoglobulin Treatment of Gestational Alloimmune Liver Disease to Prevent Neonatal Liver Failure: A Single Center Case Series
This case series indicates that weekly antenatal IVIG treatment is highly efficient to prevent GALD-associated neonatal liver failure. In contrast to other cases series, there were no major maternal side effects. An introduced novel laboratory scoring system to decide on early postnatal intervention requires validation in a larger number of neonates.
Authors
- Beate Mayer (ORCID: https://orcid.org/0000-0002-6238-8405)
- Christof Dame (ORCID: https://orcid.org/0000-0002-7303-6667)
- Caroline Gabrysch (ORCID: https://orcid.org/0000-0002-5616-7518)
- Christoph Bührer (ORCID: https://orcid.org/0000-0002-9950-414X)
- Iris Dressler‐Steinbach (ORCID: https://orcid.org/0000-0002-9448-475X)
- Stefan Verlohren
Institutions
- Humboldt-Universität zu Berlin (DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Transfusion Medicine and Hemotherapy
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1159/000548476
- Citations
- 1
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.82